GC
MLAB icon

Globeflex Capital’s Mesa Laboratories MLAB Stock Holding History

Globeflex Capital’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
11,581
+743
+7% +$74.8K 0.15% 163
2026
Q1 		$958K Buy
+10,838
New +$934K 0.15% 162

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Globeflex Capital's MLAB Position: Q2 2026 in Review

Globeflex Capital increased its Mesa Laboratories (MLAB) stake by 6.9% in Q2 2026, buying an estimated $74.8K and bringing the position to 11,581 shares worth $1.15M. The position accounts for 0.15% of the portfolio, ranked #163.

Globeflex Capital first reported a position in MLAB in Q1 2026 and has held it in 2 quarters since. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Globeflex Capital held 11,581 shares of Mesa Laboratories worth $1.15M as of Q2 2026.
  • Globeflex Capital bought 743 Mesa Laboratories shares in Q2 2026, an estimated $74.8K.
  • Mesa Laboratories made up 0.15% of Globeflex Capital's portfolio in Q2 2026, its #163 holding.
  • Globeflex Capital first reported a position in Mesa Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.